9883 Trademark

Trademark Overview

On Tuesday, June 27, 2017, a trademark application was filed for 9883 with the United States Patent and Trademark Office. The USPTO has given the 9883 trademark a serial number of 87507933. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, November 21, 2023. This trademark is owned by Gilead Sciences Ireland UC. The 9883 trademark is filed in the Pharmaceutical Products category with the following description:

Antiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection
9883

General Information

Serial Number87507933
Word Mark9883
Filing DateTuesday, June 27, 2017
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, November 21, 2023
Registration Number5467392
Registration DateTuesday, May 15, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 27, 2018

Trademark Statements

Goods and ServicesAntiviral pharmaceutical preparations; anti-infective pharmaceutical preparations; pharmaceutical preparations for treatment and prevention of HIV infection
Pseudo MarkNINE EIGHT EIGHT THREE

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 5, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGilead Sciences Ireland UC
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressCarrigtohill Co. Cork,
IE
Party NameGilead Sciences Ireland UC
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE
Party NameGilead Sciences Ireland UC
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressCarrigtohill, Co. Cork
IE

Trademark Events

Event DateEvent Description
Tuesday, November 21, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, November 21, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, November 21, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 23, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, May 15, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 11, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 11, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 11, 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, October 11, 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, October 11, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, May 15, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, February 27, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 27, 2018PUBLISHED FOR OPPOSITION
Wednesday, February 7, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, January 22, 2018ELECTRONIC RECORD REVIEW COMPLETE
Friday, January 12, 2018ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Thursday, January 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, December 28, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, December 28, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, December 26, 2017ASSIGNED TO LIE
Thursday, December 14, 2017TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, September 25, 2017NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, September 25, 2017LETTER OF SUSPENSION E-MAILED
Monday, September 25, 2017SUSPENSION LETTER WRITTEN
Sunday, September 24, 2017ASSIGNED TO EXAMINER
Wednesday, July 5, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, June 30, 2017NEW APPLICATION ENTERED

Related Keywords

pharmaceutical preparations prevention infection treatment anti antiviral infective